Nature Communications (Feb 2021)
Magneto-optical diagnosis of symptomatic malaria in Papua New Guinea
- L. Arndt,
- T. Koleala,
- Á. Orbán,
- C. Ibam,
- E. Lufele,
- L. Timinao,
- L. Lorry,
- Á. Butykai,
- P. Kaman,
- A. P. Molnár,
- S. Krohns,
- E. Nate,
- I. Kucsera,
- E. Orosz,
- B. Moore,
- L. J. Robinson,
- M. Laman,
- I. Kézsmárki,
- S. Karl
Affiliations
- L. Arndt
- Institute of Natural Materials Technology, University of Technology
- T. Koleala
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- Á. Orbán
- Department of Physics, Budapest University of Technology and Economics
- C. Ibam
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- E. Lufele
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- L. Timinao
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- L. Lorry
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- Á. Butykai
- Department of Physics, Budapest University of Technology and Economics
- P. Kaman
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- A. P. Molnár
- Department of Physics, Budapest University of Technology and Economics
- S. Krohns
- Experimental Physics 5, Center for Electronic Correlations and Magnetism, University of Augsburg
- E. Nate
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- I. Kucsera
- National Public Health Center
- E. Orosz
- National Public Health Center
- B. Moore
- School of Pharmacy, Curtin University
- L. J. Robinson
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- M. Laman
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- I. Kézsmárki
- Department of Physics, Budapest University of Technology and Economics
- S. Karl
- Vector-borne Diseases Unit, PNG Institute of Medical Research
- DOI
- https://doi.org/10.1038/s41467-021-21110-w
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 10
Abstract
Here Arndt et al. establish rotating-crystal magneto-optical detection (RMOD) as a near-point-of-care diagnostic tool for malaria detection and report a sensitivity and specificity of 82% and 84%, respectively, as validated by analyzing a clinical population in a high transmission setting in Papua New Guinea.
